Skip to main content

MAXCYTE, INC.

For the period ended Mar 31, 2026. Filed May 13, 2026.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Mar 31, 2026 · Filed May 13, 2026

MXCT$1.30+3.2%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Condensed Consolidated Balance Sheets

(in thousands, except share and per share amounts)

​​​​​​​
​ · ​ · March 31, · ​ · December 31,
​ · ​ ​ ​ · 2026 · ​ ​ ​ · 2025
​​​​​​(See Note 2)
Assets · ​ · ​ · ​ · ​ · ​
Current assets: · ​ · ​ · ​ · ​
Cash and cash equivalents​$14,557​$20,065
Short-term investments, at amortized cost​92,297​82,979
Accounts receivable, net​4,246​3,503
Inventory​7,631​7,547
Prepaid expenses and other current assets​4,206​4,275
Total current assets​122,937​118,369
​​​​​​​
Investments, non-current, at amortized cost​​40,811​​52,570
Property and equipment, net​​16,637​17,531
Right-of-use asset - operating leases​​10,699​10,920
Intangible assets, net​​783​​650
Other assets​2,606​2,467
Total assets​$194,473​$202,507
​​​​​​​
Liabilities and stockholders’ equity​​​​
Current liabilities:​​​​
Accounts payable​$1,196​$1,401
Accrued expenses and other​4,371​7,812
Operating lease liability, current​1,374​1,456
Deferred revenue, current portion​3,271​3,598
Total current liabilities​10,212​14,267
​​​​​​​
Operating lease liability, net of current portion​16,113​16,487
Other liabilities​262​263
Total liabilities​26,587​31,017
​​​​​​​
Commitments and contingencies (Note 7)​​​​
Stockholders’ equity:​​​​
Preferred stock, $0.01 par value; 5,000,000 shares authorized and no shares issued and outstanding at March 31, 2026 and December 31, 2025​​—​​—
Common stock, $0.01 par value; 400,000,000 shares authorized, 107,121,672 and 106,789,618 shares issued and outstanding at March 31, 2026 and December 31, 2025, respectively​​1,071​​1,068
Additional paid-in capital​433,048​431,905
Accumulated deficit​(266,233)​(261,483)
Total stockholders’ equity​167,886​171,490
Total liabilities and stockholders’ equity​$194,473​$202,507
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.